Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions

Size: px
Start display at page:

Download "Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions"

Transcription

1 Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions Anna Sandström The Swedish Governmental Agency for Innovation Systems VINNOVA

2 Efficient innovation systems From idea to product and/or services VINNOVA s mission is to promote sustainable growth by developing effective innovation systems and financing problem-oriented research Innovation systems analyses and international benchmarking for national strategy development Interaction between Business Research Public Sector VINNOVA: about 170 employees and a budget of almost 140 MEuro 2006

3 Idea Product Service Private foundations (e.g. for specific diseases) Swedish Foundation for Strategic Research (strategic research, peer review but top down choice of areas) Swedish Research Council (basic research, peer review) VINNOVA (needs driven research and improved innovation systems) Innovation Bridge (seed financing, incubators) Swedish Industrial Development Fund (semi public VC) Venture Capital Companies Universities and the healthcare sector Life Science Industry

4 Development of a National Biotech Strategy Examples of analyses used as input to the process Industry Production Bibliometry Pipeline Interviews Workshops Dialogue Committee Strategy Political process Foresight

5 Strategy for growth Biotechnology World International alliances Sweden Academy Industry More effective commercialisation of science Strengthened excellent science base Internationally competitive business terms Increased knowledge, dialogue, cooperation and readiness Politics and society

6 variables

7 Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Broad R&D Narrow R&D Productdevelopment Consultancy Production Wtthout wtth without with product Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food NATIONAL MARKET (eg Malmoe/Lund) Region No. employees (eg ) INTERNATIONAL MARKET Category (eg production) Marketing & sales Region (eg Malmoe/Lund)

8 Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Cluster profile Sweden - Biotechnology, Pharmaceuticals and Medical Technology Broad R&D Narrow R&D Production Wtthout wtth without with product Marketing & sales Productdevelopment Consultancy Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food

9 Share of employees in different business segments employees in total Agrobiotech 1,3% Bioproduction 2,4% Biotech tools & supplies 9% Environmental biotech 0,1% Functional food 0,2% Medical technology 26% Drug discovery & development 48% CMO 2,9% CRO 1,8% Biotech medical technology 4,5% Diagnostics 3,0% Drug delivery 0,5%

10 No. employees in different categories Broad R&D with product Broad R&D + product Broad R&D Broad R&D/large pipeline yet without product 220 Narrow R&D with product Narrow R&D + product 750 Narrow R&D Narrow R&D yet without product 320 Own productdevelopment Product development Consultancy Konsult/CRO Production units in companies with R&D and with more than 500 employees. Production Marketing and sales Production Sales Produktionsenheter inom företag med mer än 500 anställda i Sverige och som även bedriver forskning och utveckling No. employees

11 Regional distribution of the Swedish Life Science industry Other parts of Sweden 3% Umeå 2% Gothenburg 19 % Stockholm/ Uppsala 58% Linköping 1% Malmoe/ Lund 17%

12 Development companies with employees Biotech firms Pharmacia related companies Astra/AstraZeneca No. Employees

13 Biotech + Astra/AstraZeneca & Pharmacia related companies 216 companies with employees (2003) Astra/AstraZeneca Pharmacia related companies Other biotech companies No. employees AstraZeneca Astra No. employees Biacore GE Healthcare Quintiles 7000 Amersham Bioscience Active Biotech Fresenius Kabi Pharmacia Biovitrum 4000 Octapharma Pharmacia 3000 Diagnostics Pfizer No.employees ,5 percent/year, Total + 38 percent Growth of the number of employees ,0 percent/year, Total + 19 percent + 6,2 percent/year, Total + 43 percent

14 Cluster Profile, SWEDEN Biotechnology, Pharmaceuticals Medical Technology (Excluding national market and marketing/sales) Broad R&D with product Broad R&D yet without prod Narrow R&D with product Narrow R&D yet without prod Own product development Consultancy Production Business segments: Drug discovery & development Drug delivery Diagnostics Biotech medical technology CRO Umeå Uppsala Stockholm Strängnäs Linköping Gothenburg Other Malmoe/Lund K10-BP1231 Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Medicon Valley Copenhagen

National and regional cluster profiles

National and regional cluster profiles National and regional cluster profiles Companies in biotechnology, pharmaceuticals and medical technology in Sweden 2004 Working material 29/12/04 VINNOVA Analysis VA 2007:04 BioMedley This edition has

More information

Life science companies in Sweden

Life science companies in Sweden Life science companies in Sweden Including a comparison with Denmark addendi Life science companies in Sweden - Including a comparison with Denmark Anna Sandström, VINNOVA Tage Dolk och Benny Dolk, Addendi

More information

Förhandskopia 2007 12 07

Förhandskopia 2007 12 07 Förhandskopia 2007 12 07 Title: Biotechnology, pharmaceuticals and medical technology in Sweden 2007 - Cluster profiles Author: Anna Sandström and Helena Bergqvist, VINNOVA, Tage Dolk, Addendi AB Series:

More information

Globala trender med lokala effekter

Globala trender med lokala effekter Globala trender med lokala effekter Den svenska Life Science industrin 1998-212 5 Mars kl. 8.3-1. Jenni Nordborg Göran Andersson Anna Sandström Life Sciences evolutionary and iterative innovation processes

More information

Karriärdagar Uppsala - Vad händer inom bioteknikbranschen?

Karriärdagar Uppsala - Vad händer inom bioteknikbranschen? The Swedish Biotechnology Industry Organization Karriärdagar Uppsala - Vad händer inom bioteknikbranschen? Uppsala karriärdagar March 15th, 2006 Per-Erik Sandlund SwedenBIO Wallingatan 24 SE-111 24 Stockholm

More information

FACTS AND FIGURES ON SWEDEN S NUMBER ONE LIFE SCIENCE REGION

FACTS AND FIGURES ON SWEDEN S NUMBER ONE LIFE SCIENCE REGION 1 Stockholm-Uppsala: Life Science Company Report data from 2011 FACTS AND FIGURES ON SWEDEN S NUMBER ONE LIFE SCIENCE REGION Data from 2011 including comparison with 2010 and 2009 2 Stockholm-Uppsala:

More information

Life science companies in Sweden Including a comparison with Denmark

Life science companies in Sweden Including a comparison with Denmark VINNOVA ANALYSIS VA 2011:03 Life science companies in Sweden Including a comparison with Denmark Life science companies in Sweden Including a comparison with Denmark 0 addendi addendi Title: Life science

More information

LIFE SCIENCE INITIATIVES FOR TOMORROW S INNOVATIONS A FUTURE ALIVE WITH OPPORTUNITIES. Business Sweden

LIFE SCIENCE INITIATIVES FOR TOMORROW S INNOVATIONS A FUTURE ALIVE WITH OPPORTUNITIES. Business Sweden LIFE SCIENCE INITIATIVES FOR TOMORROW S INNOVATIONS A FUTURE ALIVE WITH OPPORTUNITIES INDEX LIFE SCIENCE INITIATIVES FOR TOMORROW S INNOVATIONS CONTENT Introduction - A future full of opportunities 5

More information

Swedish Industry. Biotechnology and Pharmaceuticals in Sweden

Swedish Industry. Biotechnology and Pharmaceuticals in Sweden Swedish Industry Published by the Swedish Institute AUGUST 2007 FS 132 C 132 Biotechnology and Pharmaceuticals in Sweden There are two main types of companies that utilize classical or modern biotechnology:

More information

The Swedish Drug Development Pipeline. Dec. 2013. Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal

The Swedish Drug Development Pipeline. Dec. 2013. Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal The Swedish Drug Development Pipeline & overview of companies with R&D activities in Sweden Dec. 2013 Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal

More information

READi for Health & ECHAlliance Anette Orheim

READi for Health & ECHAlliance Anette Orheim READi for Health & ECHAlliance Anette Orheim 110 41 000 25 000 80 000 17 000 75 1250 14 000 OUR MISSION At Medicon Village we want to create an environment where research, innovation and entrepreneurship

More information

The Swedish Drug Development Pipeline 2014

The Swedish Drug Development Pipeline 2014 The Swedish Drug Development Pipeline 2014 and an overview of swedish r&d companies 2013 december 2014 this report is compiled by swedenbio with support from vinnova 2 the swedish drug development pipeline

More information

The Swedish Drug Development Pipeline. December 2013. & overview of Swedish companies with R&D activities in Sweden

The Swedish Drug Development Pipeline. December 2013. & overview of Swedish companies with R&D activities in Sweden The Swedish Drug Development Pipeline & overview of Swedish companies with R&D activities in Sweden December 2013 This report is compiled by SwedenBIO with support from VINNOVA and Business Sweden Table

More information

Strategic Programme for Innovation in the Area of Chronic Diseases

Strategic Programme for Innovation in the Area of Chronic Diseases Strategic Programme for Innovation in the Area of Chronic Diseases 1 Strategic Innovation Area (max 2 A4) Many of the prerequisites for international competitiveness and sustainable solutions to meet global

More information

Calmino Group goes international with IBS treatment

Calmino Group goes international with IBS treatment Sida 1 av 7 PARKNEWS from Sahlgrenska Science Park 1 June 2016 View in the browser Calmino Group goes international with IBS treatment The company Calmino Group has started sales on the international market.

More information

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy

More information

ABOUT VA. Vetenskap & Allmänhet

ABOUT VA. Vetenskap & Allmänhet ABOUT VA 2014 Vetenskap & Allmänhet VA PROMOTES DIALOGUE AND OPENNESS BETWEEN THE PUBLIC AND RESEARCHERS VA (Public & Science) is an independent Swedish non-profit membership organisation for both organisations

More information

Life science in Oslo a potential cluster?

Life science in Oslo a potential cluster? Life science in Oslo a potential cluster? Introduction This is a paper prepared by Oslo Teknopol for the STRATINC project (May 2004). In the following we will explain our approach to the need of strategic

More information

For More Information

For More Information THE ARTS CHILD POLICY CIVIL JUSTICE EDUCATION ENERGY AND ENVIRONMENT This PDF document was made available from www.rand.org as a public service of the RAND Corporation. Jump down to document6 HEALTH AND

More information

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo 1 Overview 1. Venture Valuation 2. Trends in the EU Biotech & Pharma 3. Overview European Biotechs / Clusters 2 Valuation Valuation Mission Independent

More information

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation

More information

How world-class diabetes research will contribute to Swedish growth

How world-class diabetes research will contribute to Swedish growth 2013-04-05 How world-class diabetes research will contribute to Swedish growth A VINNOVA Innovation agenda April 2013 Karolinska Institutet Lund University Umeå University Uppsala University AstraZeneca

More information

Tech transfer The Swedish Context. Academia-industry collaboration. .. Created the largest selling drug, LOSEC, followed by Nexium

Tech transfer The Swedish Context. Academia-industry collaboration. .. Created the largest selling drug, LOSEC, followed by Nexium Tech transfer The Swedish Context Claes Post, May 21 2010, Brussels Academia-industry collaboration Scand J Gastroenterol Suppl. 1989;166:3-11.The gastric H+,K+- ATPase: the site of action of omeprazole.sachs

More information

Nordic Center for Sustainable Healthcare

Nordic Center for Sustainable Healthcare Nordic Center for Sustainable Healthcare Nordic Center for Sustainable Healthcare (NCSH) is an intersectoral arena for stakeholders, organizations, projects and expert knowledge in the sector of sustainable

More information

International Innovation Policy

International Innovation Policy International Innovation Policy The next generation of Life science Policy in Skåne Marie-Louise Eriksson, Region Skåne 20141029 Global perspective on Life science Swedish Life Science clusters Ranking

More information

2013-03-04. Kurt Strömgren. Business coach - Uminova Innovation Manager Biotech Umeå. Ideas become business.

2013-03-04. Kurt Strömgren. Business coach - Uminova Innovation Manager Biotech Umeå. Ideas become business. Kurt Strömgren Business coach - Uminova Innovation Manager Biotech Umeå Ideas become business. 1 The Umeå support system for innovations IDEA GROW EXPAND Innovationsslussen Entrepreneur center Uminova

More information

A BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS

A BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS V I N N O V A A N A L Y S I S V A 2 0 0 8 : 1 2 A BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS Comparison of policies and funding U P P S A L A U N I V E R S I T Y V I

More information

New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009

New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009 New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009 NYCEDC relationship to City Hall MAYOR Michael R. Bloomberg Deputy Mayor for Economic Development and Rebuilding

More information

Investigating the Uppsala Biotech Cluster

Investigating the Uppsala Biotech Cluster Investigating the Uppsala Biotech Cluster Robin Teigland Göran Lindqvist Anders Malmberg Anders Waxell research paper 2004:1 Investigating the Uppsala Biotech Cluster Baseline Results from the 2004 Uppsala

More information

Legislative Council Secretariat FACT SHEET. Pharmaceutical industry in Denmark

Legislative Council Secretariat FACT SHEET. Pharmaceutical industry in Denmark FACT SHEET Pharmaceutical industry in Denmark 1. Introduction 1.1 The Danish pharmaceutical industry is known worldwide for providing quality drugs and medical products. In 2012, Denmark was the 16 th

More information

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight

More information

Cluster Formation Across Borders

Cluster Formation Across Borders Cluster Formation Across Borders Clusters in the Oresund Region by Torben Orla Nielsen Berlin November 13 th, 2007 Agenda The Region Øresund Science Region Status for Cluster Open Innovation Process Ambassador

More information

The boards also have the task of vetting certain issues in accordance with the Biobanks in Medical Care Act (2002:297).

The boards also have the task of vetting certain issues in accordance with the Biobanks in Medical Care Act (2002:297). Please note that errors may occur in the wording of statutes. In most cases the annexes are included. However, given the technology currently in use, annexes consisting of images, maps and listings in

More information

Selling an Idea. Dr. Mark McHale Chief Scientific Officer ASLAN Pharmaceuticals Singapore

Selling an Idea. Dr. Mark McHale Chief Scientific Officer ASLAN Pharmaceuticals Singapore Selling an Idea Dr. Mark McHale Chief Scientific Officer ASLAN Pharmaceuticals Singapore Seminar Format XXXX Know Your Stuff Andy Murray The Beetles Read everything in your field Keep up to date Be dedicated

More information

improving nature s own defense mechanisms Company presentation

improving nature s own defense mechanisms Company presentation improving nature s own defense mechanisms Company presentation August 2013 Lytix Biopharma AS Norwegian non-listed company Founded 2003 Tromsø Aims to develop novel therapeutics for areas of high unmet

More information

The medical research situation in Sweden Preface

The medical research situation in Sweden Preface The medical research situation in Sweden Preface In cooperation with the six Swedish medical faculties, the Scientific Council for Medicine at the Swedish Research Council (SRC) appointed an inquiry group

More information

Infrastructure and users Public and private providers/users Issues and approaches Discussion

Infrastructure and users Public and private providers/users Issues and approaches Discussion Henrik Hansson Department of Computer and Systems Sciences Stockholm University Sweden elearning Baltics Rostock 1 2 July 2010 Infrastructure and users Public and private providers/users Issues and approaches

More information

SYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE 2015-02-06

SYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE 2015-02-06 SYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE 2015-02-06 AGENDA Welcome to SICS and INCOSE Sweden 10 min Purpose of WS 3 min Short presentation of everyone 15 min Background: The SoS Agenda project

More information

Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness

Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness 2015 Healthcare Healthcare Korea's healthcare industry is growing thanks to the advancement of the production infrastructure of pharmaceuticals, medical devices and cosmetics, support for healthcare-related

More information

E- MARKETPLACES IN THE BIOTECH INDUSTRY

E- MARKETPLACES IN THE BIOTECH INDUSTRY E- MARKETPLACES IN THE BIOTECH INDUSTRY By Jonas Bygdeson, Head of emarket Services Swedish Trade Council www.emarketservices.com May 2004 Abstract The purpose of this report is to study how electronic

More information

Curriculum Vitae PERSONAL DETAILS. Place/Date of Birth: For Lauderdale, Florida. February 7, 1962. USA, permanent resident of Sweden

Curriculum Vitae PERSONAL DETAILS. Place/Date of Birth: For Lauderdale, Florida. February 7, 1962. USA, permanent resident of Sweden Curriculum Vitae Sarah Merritt Polk PERSONAL DETAILS Place/Date of Birth: For Lauderdale, Florida. February 7, 1962. Nationality: USA, permanent resident of Sweden Current position: Work address: University

More information

Creative Force Eastern Europe and Western Balkans

Creative Force Eastern Europe and Western Balkans Page: 1 (2) Creative Force Eastern Europe and Western Balkans Seed funding granted 2013-10-15 (Dnr 09476/2013) awarde d (in Kvinnofolkhögskol an Göteborg (10879/2013) SEK) Edumama Ukraine 30 130 Poppius

More information

Event Sponsorship Opportunities

Event Sponsorship Opportunities Event Sponsorship Opportunities Creating Value for Your Company Sponsoring Medicon Valley Alliance provides you with unique access to life science professionals in Denmark and Sweden. Through a range of

More information

Performance indicators, quality benchmarking and cost/ efficiency of emergency services. Gunnar Bergström SOS Alarm, Sweden

Performance indicators, quality benchmarking and cost/ efficiency of emergency services. Gunnar Bergström SOS Alarm, Sweden Performance indicators, quality benchmarking and cost/ efficiency of emergency services Gunnar Bergström SOS Alarm, Sweden SHORT INFO SOS Alarm is owned by the Government and the Swedish Association of

More information

Finnish Experiences in Technology Foresight

Finnish Experiences in Technology Foresight The Third Generation Foresight and Prioritization in Science and Technology Policy 27.-28 February 2003, Japan Finnish Experiences in Technology Foresight Eija Ahola, Tekes Technology foresight within

More information

Interactions between academia and the pharmaceutical industry

Interactions between academia and the pharmaceutical industry Interactions between academia and the pharmaceutical industry Some experiences on understanding the other side Per J. Kraulis Academia and Industry Pharmaceuticals, medicine, biotech In general: Good relations

More information

STATE OF MEDICON VALLEY An Analysis of Life Science in Greater Copenhagen

STATE OF MEDICON VALLEY An Analysis of Life Science in Greater Copenhagen STATE OF MEDICON VALLEY 2016 An Analysis of Life Science in Greater Copenhagen PREFACE Life science in Denmark and Sweden has developed in different directions over the past decade. Danish life science

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?

More information

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,

More information

PDP Funders Group Briefing Paper 3. 1. Background. 2. Methods

PDP Funders Group Briefing Paper 3. 1. Background. 2. Methods PRODUCT DEVELOPMENT PARTNERSHIPS (PDPS): WORKING TOGETHER: COLLABORATIONS BETWEEN PDPS AND PHARMACEUTICAL BIOTECHNOLOGY COMPANIES BASED IN EMERGING AND DEVELOPING ECONOMIES 1. Background Product Development

More information

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific

More information

Egon Zehnder International

Egon Zehnder International Egon Zehnder I. ID info about yourself Work-setting Preferences Personal Skills Inventory Motivational Factors III. Targeting your employer Narrowing the field Aligning credentials Optimizing documents

More information

Biotechnology Report. Estonia

Biotechnology Report. Estonia Biotechnology Report Estonia PREPARED BY AND IN Cyprus Bulgaria Croatia Czech Estonia Industry Republic Report STATUS OF THE ESTONIAN BIOTECHNOLOGY SECTOR (Financial data in ) (Financial data in ) (Financial

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Can public policy regenerate a traditional industry through collaborative research? The case of the Swedish food industry

Can public policy regenerate a traditional industry through collaborative research? The case of the Swedish food industry Paper to be presented at the DRUID Society Conference 2014, CBS, Copenhagen, June 16-18 Can public policy regenerate a traditional industry through collaborative research? The case of the Swedish food

More information

Business Incubation for Growth, BIG: A new national incubator program

Business Incubation for Growth, BIG: A new national incubator program Business Incubation for Growth, BIG: A new national incubator program Workshop on Innovation Policy in the Recession Birkbeck, London, 15 October 2012 Åsa Lindholm Dahlstrand CIRCLE Lund University, Sweden

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

Analysis of Chain-linked

Analysis of Chain-linked VINNOVA Analysis VA 2009:20 Analysis of Chain-linked Effects of Public Policy Effects on research and industry in Swedish life sciences within innovative food and medical technology Jens Laage-Hellman,

More information

National Doctoral Programme in Infections and Antibiotics

National Doctoral Programme in Infections and Antibiotics Åke Forsberg National Coordinator Anna Holmström National Director of Studies MIMS-affiliated National Doctoral Programme in Infections and Antibiotics (NDPIA) Dept. of Molecular Biology/MIMS Umeå University

More information

GREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2

GREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2 GREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2 FINAL VERSION 4/10/2012 Safe and Green Road Vehicles Europe Main and corresponding author: Hans Fogelberg, Region Västra

More information

The Swedish Drug Development Pipeline June 2012. A survey conducted by:

The Swedish Drug Development Pipeline June 2012. A survey conducted by: The Swedish Drug Development Pipeline June 2012 A survey conducted by: Key findings More companies report clinical trials There has been a increase in number of companies contributing with information

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many

More information

Corporate Governance Report for Orexo AB (publ)

Corporate Governance Report for Orexo AB (publ) Corporate Governance Report for Orexo AB (publ) Orexo is a Swedish public limited liability company with registered offices in Uppsala, Sweden. The company s shares are listed on Nasdaq (Mid Cap) Stockholm,

More information

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover The rocky way from science to market Dr. Karsten Fischer BioMedPartners AG VPM Days Hannover November 2013 Content I. Stage 1 II. Setbacks 6 III. Hope 12 IV. Solutions 17 V. Expertise 20 Page 1 The Challenge

More information

R&D for Development of New Drugs for Neglected Diseases: A Proposal for South South Cooperation

R&D for Development of New Drugs for Neglected Diseases: A Proposal for South South Cooperation R&D for Development of New Drugs for Neglected Diseases: A Proposal for South South Cooperation Sudip Chaudhuri Indian Institute of Management Calcutta DNDi Intellectual Property Workshop New Delhi 4 December,

More information

CURRICULUM VITAE (short version)

CURRICULUM VITAE (short version) 1 CURRICULUM VITAE (short version) Hans Löfsten, Professor (Chair) Professor, Chair of Engineering Economic Analysis (Teknikens ekonomiska analys), Chalmers University of Technology, Department of Technology

More information

VTT Technical Research Centre of Finland 2010

VTT Technical Research Centre of Finland 2010 VTT Technical Research Centre of Finland 2010 02/04/2010 2 GDP share of R&D expenditure in Finland % 3 3.43 3.45 3.48 3.45 3.47 3.72 3.92 2.1 1990 1998 2003 2004 2005 2006 2007 2008 2009 Source: Statistics

More information

Appendix 4. Areas visited in UK and US UK AREAS VISITED

Appendix 4. Areas visited in UK and US UK AREAS VISITED Areas visited in UK and US UK AREAS VISITED CAMBRIDGE Science base: A centre of scientific excellence represented by the University, and institutes such as: Laboratory of Molecular Biology, Babraham Institute,

More information

Career Opportunities in the Life Sciences

Career Opportunities in the Life Sciences Career Opportunities in Biotechnology and Drug Career Opportunities in the Life Sciences Toby Beth Freedman, Ph.D. February 28 th, 2008 1 The Experiment A comprehensive, systematic assessment of careers

More information

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in

More information

Redeye March Gunnar Casserstedt

Redeye March Gunnar Casserstedt Redeye March 24 2009 Gunnar Casserstedt The Space in Which Karolinska Development Operates 70 60-50 50-40 40 30 20 Innovation Gap -30-20 10 0-10 New Drug Approvals PhRMA member R&D spending 1993 1994 1995

More information

ACC San Diego Chapter

ACC San Diego Chapter ACC San Diego Chapter Biomedical and Technology Collaborations with Chinese Companies: Legal and Cultural Challenges October 2012 DLA Piper Overview Our Firm 4,200 lawyers in 77 offices and 33 countries

More information

Biotech Opportunities for Start-Up Firms in Japan and Asia

Biotech Opportunities for Start-Up Firms in Japan and Asia Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma

More information

HCL Healthcare: Meeting Reform Challenges

HCL Healthcare: Meeting Reform Challenges HCL Healthcare: Meeting Reform Challenges Pradep Nair Senior Vice President Healthcare Practice pnair@hcl.com Agenda Healthcare Industry: Drivers of Change HCL Healthcare Overview Healthcare Sub-Verticals

More information

The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland

The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland EpiScania Symposium Medicon Village, Lund 2 nd September 2015 The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland Peter M Nilsson, MD, PhD Department of

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2016 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

www.ivf.se Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild 1 2005-10-24

www.ivf.se Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild 1 2005-10-24 Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild 1 2005-10-24 IVF Industrial Research and Development Corporation IVF is the Swedish engineering industry's

More information

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE University of Cambridge: Programme Specifications Every effort has been made to ensure the accuracy of the information in this programme specification. Programme specifications are produced and then reviewed

More information

Blekinge Institute of Technology. Master Thesis

Blekinge Institute of Technology. Master Thesis Blekinge Institute of Technology School of Management Master Thesis Identifying and Ranking of Critical Success Factors for Biotech Startups- An Empirical Study of Biotechnology Firms in Sweden Supervisor:

More information

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams

More information

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge

More information

Denmark. Aarhus University. Aalborg University. University of Copenhagen. IT University of Copenhagen. Nordic Techology Transfer Network

Denmark. Aarhus University. Aalborg University. University of Copenhagen. IT University of Copenhagen. Nordic Techology Transfer Network Denmark Aarhus University Patent and Contract Department http://www.au.dk/da/adm/led/pke E mail: pke(at)au.dk Tel: +45 89426884 Aalborg University Patent and Contract Department http://patent.aau.dk/ E

More information

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies Greetings from Chicago! Beaches Yes! Pharma Beginnings! Bogota 1974 Selling Drugs in Colombia Global

More information

Trends in Innovation in Middle Income Countries: The Case of Biotechnology

Trends in Innovation in Middle Income Countries: The Case of Biotechnology Trends in Innovation in Middle Income Countries: The Case of Biotechnology Joseph Damond, Senior Vice President, International Affairs, Biotechnology Industry Organization INNOVATION AND ACCESS TO MEDICAL

More information

Nordic Venture Capital:

Nordic Venture Capital: Menon Publication Nordic Venture Capital: Cross Border Investments MENON-PUBLICATION NO. 20 /2010 Gjermund Grimsby, Leo A. Grünfeld and Anne Espelien www.menon.no PO. Box 5250 Majorstuen N0303 Oslo Tel:

More information

OPPORTUNITY AFRICAN MARKET FOR INDIAN COMPANIES

OPPORTUNITY AFRICAN MARKET FOR INDIAN COMPANIES OPPORTUNITY AFRICAN MARKET FOR INDIAN COMPANIES G.K. Raman Regional Director PHARMEXCIL INDIAN PHARMACEUTICAL INDSTRY Manufacturers over 400 APIs (BULK DRUGS) Manufacturers over 10,000 medicaments (Formulations)

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Life Sciences Outlook. New Jersey 2015

Life Sciences Outlook. New Jersey 2015 Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping

More information

Economic and Social Council

Economic and Social Council UNITED NATIONS E Economic and Social Council Distr. GENERAL TRANS/SC.2/2003/15 4 August 2003 Original: ENGLISH ECONOMIC COMMISSION FOR EUROPE INLAND TRANSPORT COMMITTEE Working Party on Rail Transport

More information

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset Introduction In this era of strategic development deals, inventiv Health has significantly broadened

More information

Six Sigma Workshop Fallstudie och praktisk övning

Six Sigma Workshop Fallstudie och praktisk övning Six Sigma Workshop Fallstudie och praktisk övning 0-fels LEAN-konferens, Folkets Hus 05-NOV-2013 Lars Öst GE business segments Technology Infrastructure Energy Infrastructure GE Capital NBC Universal Healthcare

More information

TOPRA 2014 TOPRA IN SWEDEN. Margareth Jorvid TOPRA In Sweden Working Party

TOPRA 2014 TOPRA IN SWEDEN. Margareth Jorvid TOPRA In Sweden Working Party TOPRA 2014 TOPRA IN SWEDEN Margareth Jorvid TOPRA In Sweden Working Party ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION Kliniska studier av läkemedel och medicinteknik dagens

More information

The Novo Nordisk Foundation Center for Biosustanability, DTU. Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO.

The Novo Nordisk Foundation Center for Biosustanability, DTU. Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO. The Novo Nordisk Foundation Center for Biosustanability, DTU Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO. Center for Biosustainability BIOSUSTAINABILITY: through metabolic

More information

Knowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, 2016. Copyright 2016 Isis Innovation Ltd.

Knowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, 2016. Copyright 2016 Isis Innovation Ltd. Knowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, 2016 Mireya McKee Education SI Dip PhD BSc Senior Consultant Mireya McKee 15+ years experience in chemistry,

More information

Photocure ASA. The world leader in photodynamic technology. Sept 2011. Ketil F. Widerberg, Director Business Development

Photocure ASA. The world leader in photodynamic technology. Sept 2011. Ketil F. Widerberg, Director Business Development Brilliance in photodynamic technology Photocure ASA The world leader in photodynamic technology Sept 2011 Ketil F. Widerberg, Director Business Development Photocure Mission Mission To bring innovative

More information

PRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden

PRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden PRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden Contents Many PRT studies & activities in Sweden Mega-study: 15 % higher modal share with PRT Recent PRT studies in

More information

International Council on Systems Engineering. ISO/IEC/IEEE 15288 SEminar Linköping 16 november 2015

International Council on Systems Engineering. ISO/IEC/IEEE 15288 SEminar Linköping 16 november 2015 International Council on Systems Engineering ISO/IEC/IEEE 15288 SEminar Linköping 16 november 2015 WHY there is a need for SE and INCOSE Need to manage increasing complexity Technology trends Systems of

More information

allvarligt läge en rapport om svensk odontologisk forskning

allvarligt läge en rapport om svensk odontologisk forskning allvarligt läge en rapport om svensk odontologisk forskning VETENSKAPSRÅDETS RAPPORTSERIE 3:2007 Allvarligt läge en rapport om svensk odontologisk forskning ALLVARLIGT LÄGE en rapport om svensk odontologisk

More information

State of the Life Sciences Mergers and Acquisitions Market

State of the Life Sciences Mergers and Acquisitions Market State of the Life Sciences Mergers and Acquisitions Market Brian Miller, Managing Partner and Co-Founder, Linden Partners Rich Fante, RF Consulting LLC, Formerly with AstraZeneca Americas Mark Nicholson,

More information